Publication date: Jul 08, 2025 Pre-extensively drug-resistant tuberculosis (pre-XDR-TB) remains a critical public health threat due to limited treatment options and significant disease burden. Existing regimens have shown high success ... Read more

Publication date: Jul 01, 2025 Pulmonary cavities in patients with tuberculosis contribute to antibiotic failure, transmission, morbidity, and mortality. We aimed to report the treatment outcomes and risk factors for ... Read more

Publication date: Jul 01, 2025 Drug-resistant tuberculosis has emerged as a major public health issue that requires immediate attention. NTS is an innovative method that allows for the direct detection ... Read more

Publication date: May 17, 2025 Tuberculosis remains a significant public health challenge globally. The emergence of multidrug-resistant Mycobacterium tuberculosis strains presents one of the biggest hurdles in tuberculosis management. Both ... Read more

Publication date: Jun 19, 2025 Tuberculosis (TB), primarily caused by Mycobacterium tuberculosis complex (MTBC), remains a global health challenge and can lead to severe pulmonary and extrapulmonary complications. Multidrug-resistant TB ... Read more

Publication date: Jun 18, 2025 Long-term transmission of multidrug-resistant tuberculosis (MDR-TB) challenges TB control by generating new cases and enabling the emergence of extensively resistant strains. We investigated its epidemiologic ... Read more

Publication date: May 26, 2025 Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global health challenge, particularly with the emergence of multidrug-resistant and extensively drug-resistant strains. Mycolic acid biosynthesis ... Read more

Publication date: Jul 01, 2025 Assess the effectiveness of bedaquiline, pretomanid and linezolid (BPaL) regimens with varying doses and duration of linezolid at the end of 48 weeks post treatment ... Read more